Viemed Healthcare, Inc. (VMD) stock
VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3020% below fair value
$9.17+0.06 (+0.66%)
Close on Nov 13, 2026Market cap $349.27MP/E 24.1Yield –
Viemed Healthcare total assets
Total assets on the balance sheet at the end of each period.
Viemed Healthcare's total assets was $207.63M at Sep 30, 2026. For fiscal 2025 it was $199.15M, up 12.5% from the year before. The highest annual figure on record is $199.15M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $199.15M | +12.5% |
| FY2024 | Dec 31, 2024 | $177.07M | +14.3% |
| FY2023 | Dec 31, 2023 | $154.90M | +32.3% |
| FY2022 | Dec 31, 2022 | $117.04M | -0.8% |
| FY2021 | Dec 31, 2021 | $117.96M | +4.8% |
| FY2020 | Dec 31, 2020 | $112.56M | +36.3% |
| FY2019 | Dec 31, 2019 | $82.60M | +53.9% |
| FY2018 | Dec 31, 2018 | $53.65M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $207.63M | +2.6% |
| Q2 FY2026 | Jun 30, 2026 | $204.22M | +10.6% |
| Q1 FY2026 | Mar 31, 2026 | $197.36M | +10.8% |
| Q4 FY2025 | Dec 31, 2025 | $199.15M | +12.5% |
| Q3 FY2025 | Sep 30, 2025 | $202.36M | +19.4% |
| Q2 FY2025 | Jun 30, 2025 | $184.60M | +12.6% |
| Q1 FY2025 | Mar 31, 2025 | $178.08M | +15.0% |
| Q4 FY2024 | Dec 31, 2024 | $177.07M | +14.3% |
| Q3 FY2024 | Sep 30, 2024 | $169.53M | +13.5% |
| Q2 FY2024 | Jun 30, 2024 | $163.95M | +9.9% |
| Q1 FY2024 | Mar 31, 2024 | $154.88M | +24.3% |
| Q4 FY2023 | Dec 31, 2023 | $154.90M | +32.3% |
| Q3 FY2023 | Sep 30, 2023 | $149.40M | +25.1% |
| Q2 FY2023 | Jun 30, 2023 | $149.12M | +28.7% |
| Q1 FY2023 | Mar 31, 2023 | $124.63M | +4.7% |
| Q4 FY2022 | Dec 31, 2022 | $117.04M | -0.8% |
| Q3 FY2022 | Sep 30, 2022 | $119.42M | +3.4% |
| Q2 FY2022 | Jun 30, 2022 | $115.90M | +4.4% |
| Q1 FY2022 | Mar 31, 2022 | $119.01M | +5.3% |
| Q4 FY2021 | Dec 31, 2021 | $117.96M | +4.8% |
| Q3 FY2021 | Sep 30, 2021 | $115.49M | +1.3% |
| Q2 FY2021 | Jun 30, 2021 | $111.01M | -1.0% |
| Q1 FY2021 | Mar 31, 2021 | $113.00M | +30.2% |
| Q4 FY2020 | Dec 31, 2020 | $112.56M | +36.3% |
| Q3 FY2020 | Sep 30, 2020 | $113.97M | +42.5% |
| Q2 FY2020 | Jun 30, 2020 | $112.18M | +58.0% |
| Q1 FY2020 | Mar 31, 2020 | $86.80M | +47.8% |
| Q4 FY2019 | Dec 31, 2019 | $82.60M | +53.9% |
| Q3 FY2019 | Sep 30, 2019 | $79.98M | +62.4% |
| Q2 FY2019 | Jun 30, 2019 | $71.01M | +60.5% |
| Q1 FY2019 | Mar 31, 2019 | $58.72M | +44.4% |
| Q4 FY2018 | Dec 31, 2018 | $53.65M | – |
| Q3 FY2018 | Sep 30, 2018 | $49.24M | – |
| Q2 FY2018 | Jun 30, 2018 | $44.26M | – |
| Q1 FY2018 | Mar 31, 2018 | $40.66M | – |
See a number that looks wrong?